Skip to content
healthcare.dev

AXTLE

NDC 83831-131, pemetrexed, injection, powder, lyophilized, for solution, from Avyxa Pharma, LLC.

Product NDC
83831-131
Status
Listed
Labeler
Avyxa Pharma, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210661
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83831-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEMETREXED100 mg/4mL

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
83831-131-01838310131011 VIAL in 1 CARTON (83831-131-01) / 4 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9582c46c-d8b0-44b7-a2ee-9c86f5e9b7b1
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83831-131

Use it

Look up 83831-131 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83831-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83831-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.